| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 19, 2022 | XTNT Xtant Medical Holdings, Inc. | Browne Sean E | President And CEO | Sell | 131,100 | $0.65 | $85,827.97 | -4.1% | +3.1% | +75.8% | |
| Oct 19, 2022 | RBOT Vicarious Surgical Inc. | Kelly William John85 | CFO And Treasurer | Sell | 8,624 | $3.43 | $29,617.30 | -1.3% | -17.6% | -88.6% | |
| Oct 18, 2022 | AHCO Adapthealth Corp. | Everest Hill Group Inc.86 | 10% Owner | Sell | 105,395 | $21.05 | $2,218,690.00 | -0.4% | +2.9% | -64.7% | |
| Oct 18, 2022 | MASS 908 Devices Inc. | Knopp Kevin J.79 | President And CEO | Sell | 30,000 | $15.08 | $452,432.00 | -2.9% | -37.7% | -63.4% | |
| Oct 18, 2022 | WRBY Warby Parker Inc. | Durable Capital Partners LP56 | 10% Owner | Sell | 1,050,222 | $15.17 | $15,934,037.50 | -0.3% | +11.3% | -4.5% | |
| Oct 18, 2022 | RBOT Vicarious Surgical Inc. | Khalifa Sammy84 | Chief Technology Officer | Sell | 11,349 | $3.46 | $39,289.93 | -0.6% | -20.2% | -88.3% | |
| Oct 17, 2022 | BSX Boston Scientific Corp | Carruthers Wendy | EVP, Human Resources | Sell | 13,322 | $40.52 | $539,743.49 | -12.1% | +12.7% | +23.5% | |
| Oct 17, 2022 | SIBN Si-Bone, Inc. | Recupero Anthony J63 | President, Commercial Ops | Sell | 587 | $18.52 | $10,872.30 | -0.3% | -14.1% | -5.1% | |
| Oct 17, 2022 | SIBN Si-Bone, Inc. | Pisetsky Michael A68 | SVP, Ops &Adm/ Chief Legal Ofr | Sell | 355 | $18.39 | $6,527.35 | -0.3% | -14.1% | -5.1% | |
| Oct 17, 2022 | SIBN Si-Bone, Inc. | Dunn Jeffrey W70 | Director | Sell | 2,114 | $18.34 | $38,772.03 | -1.8% | -14.1% | -5.1% | |
| Oct 17, 2022 | RMD Resmed Inc | Farrell Michael J.63 | Chief Executive Officer | Sell | 5,675 | $214.58 | $1,217,723.34 | -1.3% | +5.0% | -33.9% | |
| Oct 17, 2022 | LFWD Lifeward Ltd. | Lind Global Fund II LP51 | 10% Owner | Buy | 62,238 | $0.82 | $50,950.22 | +0.2% | +1.6% | -16.0% | |
| Oct 14, 2022 | EW Edwards Lifesciences Corp | Chopra Daveen59 | Cvp, Surgical Structural Heart | Sell | 4,000 | $84.77 | $339,080.00 | -17.5% | -5.7% | -14.1% | |
| Oct 14, 2022 | MDT Medtronic Plc | Ten Hoedt Rob61 | EVP And Pres. Global Regions | Sell | 2,404 | $81.54 | $196,014.95 | -5.2% | -2.2% | -11.8% | |
| Oct 14, 2022 | EW Edwards Lifesciences Corp | Mussallem Michael A65 | Chairman &CEO | Sell | 19,875 | $82.84 | $1,646,523.41 | -2.7% | -5.7% | -14.1% | |
| Oct 14, 2022 | RMD Resmed Inc | Douglas Robert Andrew71 | President And COO | Sell | 11,355 | $215.09 | $2,442,298.12 | -24.5% | +1.3% | -33.6% | |
| Oct 14, 2022 | BLFS Biolife Solutions Inc | Schulz Marcus71 | Chief Revenue Officer | Sell | 236 | $21.80 | $5,144.80 | -0.7% | +15.7% | -40.6% | |
| Oct 13, 2022 | AHCO Adapthealth Corp. | Everest Hill Group Inc.86 | 10% Owner | Sell | 110,602 | $22.01 | $2,433,918.67 | -0.8% | -7.5% | -66.1% | |
| Oct 13, 2022 | NVCR Novocure Ltd | Leonard Frank X76 | President, Cns Cancers Us | Sell | 6,754 | $76.01 | $513,371.54 | -13.4% | +24.5% | -81.7% | |
| Oct 12, 2022 | ANGO Angiodynamics Inc | Trowbridge Stephen A | EVP And CFO | Buy | 1,083 | $13.82 | $14,967.06 | +1.2% | -4.1% | -54.4% | |
| Oct 11, 2022 | TELA Tela Bio, Inc. | Opaleye Management Inc.60 | 10% Owner | Buy | 16,000 | $8.00 | $128,000.00 | +0.8% | +44.3% | -19.5% | |
| Oct 11, 2022 | NEOG Neogen Corp | Quinlan Steven J.67 | VP &CFO | Buy | 5,000 | $11.63 | $58,150.00 | +18.0% | +45.9% | +28.2% | |
| Oct 11, 2022 | EW Edwards Lifesciences Corp | Wood Larry L67 | Cvp, Tavr | Sell | 7,242 | $82.12 | $594,713.04 | -3.5% | -7.1% | -13.4% | |
| Oct 11, 2022 | STIM Neuronetics, Inc. | Furlong Stephen74 | CFO | Sell | 1,630 | $2.97 | $4,841.10 | -0.4% | +129.8% | -57.9% | |
| Oct 11, 2022 | MXCT Maxcyte, Inc. | Ross Thomas M.82 | EVP, Global Sales &Marketing | Sell | 29,133 | $6.46 | $188,164.77 | -100% | -16.7% | -51.5% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.